T-REX: Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation

Sponsor
San Luigi Gonzaga Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05782738
Collaborator
(none)
361
5
2
72
72.2
1

Study Details

Study Description

Brief Summary

The Reverse T-stenting And Minimal Protrusion (Reverse TAP) is an up-front 2-stent technique that treats complex coronary bifurcation. Compared to crush techniques, it does not require crushing of the side branch stent but only minimal protrusion of the side branch stent before main vessel stenting. Nowadays, no studies compare the Reverse-TAP and the External Minicrush in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Percutaneous Coronary Intervention
N/A

Detailed Description

According to DEFINITION criteria, PCI of the complex coronary bifurcation with up-front two stent techniques is associated with lower target vessel revascularisation (TVR) than Provisional Stenting. The Double-Kissing Crush stenting (DK-Crush) has been tested with the Culotte and the Classic Crush techniques in the unprotected left main disease (ULMD) and in no-ULMD setting, respectively, showing better clinical outcomes. However, due to its technical complexity and simultaneous improvement of the Classic Crush technique in the External Minicrush, the latter has become the most used technique in the clinical practice in treating complex coronary bifurcation. The DK-Crush technique has never been tested with the External Minicrush, leaving the operators to choose one or the other according to their experience and preferences. The Reverse T-stenting, And Minimal Protrusion (Reverse TAP) is an up-front 2-stent technique that treats complex coronary bifurcation. Compared to crush techniques, it does not require crushing of the side branch stent but only minimal protrusion of the side branch stent before main vessel stenting. Nowadays, studies need to compare the Reverse-TAP and the External Minicrush in treating complex coronary bifurcation, so eventually, procedural, clinical and safety differences remain unknown.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
361 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Randomized Clinical Study Comparing Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation (T-REX Trial)
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2026
Anticipated Study Completion Date :
Jun 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Reverse TAP

Procedure: Percutaneous Coronary Intervention
Use dedicated two stents technique for treatment of coronary bifurcation stenosis

Active Comparator: External Minicrush

Procedure: Percutaneous Coronary Intervention
Use dedicated two stents technique for treatment of coronary bifurcation stenosis

Outcome Measures

Primary Outcome Measures

  1. Target Lesion Failure (TLF) (Composite of all causes of death, non-fatal TVMI, ischemia-driven target lesion revascularisation (TLR) + Definite or probable ST+ ISR >50% at planned coronary angiography or Coro-TC. [12-moths]

    We will investigate technical and clinical performance between the two techniques through coronary angiography or Coro-TC (centre preferences).

Secondary Outcome Measures

  1. Cardiac death + TVMI + ST [5-years]

    We will investigate mid-term cardiovascular clinical performance between the two techniques.

  2. Cardiac death + TVMI + ST +TLR [5-years]

    We will investigate mid-term cardiovascular clinical performance between the two techniques, including any revascularization of the target lesion site.

Other Outcome Measures

  1. Acute closure of the side branch and periprocedural-MI. [Periprocedural]

    We will investigate safety procedural profile between two techniques.

  2. Intraprocedural ST and periprocedural-MI [Periprocedural]

    We will investigate safety procedural profile between two techniques.

  3. Major bleeding (BARC 3 and 5) [5-years]

    We will investigate safety hemorrhagic profile between two techniques in consideration of prolonged DAPT.

  4. Technical success [Procedural]

    defined as TIMI flow 3 and < 30% residual stenosis after PCI on target vessel

  5. Procedural success [Periprocedural]

    Defined as technical success with no in-hospital major adverse

  6. Cross-over between groups [Periprocedural]

    Possibility to switching between two techniques for technical reasons

  7. Timing of rewiring [Periprocedural]

    Measure of the time spending in a crucial phase of the two techniques

  8. Number of guide wire used [Periprocedural]

    Number of coronary guidewires to perform the assigned technique.

  9. Amount of contrast medium used [Periprocedural]

    Total contrast medium used to perform the PCI with the technique assigned

  10. Procedural time [Periprocedural]

    Total time used to perform the PCI

  11. Fluoroscopic time [Periprocedural]

    Total fluoroscopic time spending to perform the PCI

  12. X-rays exposition [Periprocedural]

    Total operators x-rays exposition during the PCI

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients >18 years old;

  • Patients with an indication of PCI, including Chronic Coronary syndrome (CCS) and Acute Coronary Syndrome (ACS), according to current guidelines recommendations; According to Medina and Definition criteria, patients with at least true and complex coronary lesions involved in coronary bifurcation.

Exclusion Criteria:
  • Patients that refused informed consent;

  • Patients without valid vascular access that could make unsafe PCI;

  • Patients with an expected life of less than one year;

  • Patients with scheduled major surgery that required prolonged DAPT interruption;

  • Pregnant patients;

  • Patients with DAPT contraindications.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ciriè Hospital Ciriè Tori O Italy 10073
2 Ospedale Santa Croce Moncalieri Torino Italy 10024
3 Azienda ospedaliera Santi Antonio e Biagio e Cesare Arrigo Alessandria Italy 15121
4 L'Azienda Ospedaliera (AO) S. Croce e Carle Cuneo Italy 12100
5 Interventional Unit, San Luigi Gonzaga University Hospital, Orbassano, and Rivoli Hospital, Turin, Italy Turin Italy 10100

Sponsors and Collaborators

  • San Luigi Gonzaga Hospital

Investigators

  • Principal Investigator: Giulio Piedimonte, MD, Ospedale degli Infermi di Rivoli (TO)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Enrico Cerrato, Interventional Cardiology, San Luigi Gonzaga Hospital
ClinicalTrials.gov Identifier:
NCT05782738
Other Study ID Numbers:
  • 001-2023
First Posted:
Mar 24, 2023
Last Update Posted:
Mar 24, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Enrico Cerrato, Interventional Cardiology, San Luigi Gonzaga Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2023